Rare Disease Report

Poster Session: Effects of Lomitapide in Patients with HoFH

JANUARY 23, 2013

Marina Cuchel M.D.  Assistant Professor of Medicine at the University of Pennsylvania School of Medicine recently provided Rare Disease Report an exclusive look at her poster presentation of lomitapide's efficacy and safety in patients with homozygous familial hypercholesterolemia.  This data was later published in The Lancet.

For more details of this study, lomitapide, and HoFH, please go to our accompanying article.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.